{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:47:58Z","timestamp":1793015278492,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Japan Tobacco Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alzheimer\u2019s disease (AD) is the most common form of dementia. Although drugs focusing on reducing amyloid \u03b2 slow progression, they fail to improve cognitive function. Deficits in glucose metabolism are reflected in FDG-PET and parallel the neurodegeneration and synaptic marker loss closely preceding cognitive decline, but the role of metabolic deficits as a cause or consequence of neurodegeneration is unclear. Pyruvate dehydrogenase (PDH) is lost in AD and an important enzyme connecting glycolysis and the tricarboxylic acid (TCA) cycle by converting pyruvate into acetyl-CoA. It is negatively regulated by pyruvate dehydrogenase kinase (PDHK) through phosphorylation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In the present study, we assessed the in vitro\/ in vivo pharmacological profile of the novel PDHK inhibitor that we discovered, Compound A. We also assessed the effects of Compound A on AD-related phenotypes including neuron loss and cognitive impairment using 5xFAD model mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compound A inhibited human PDHK1, 2 and 3 but had no inhibitory activity on PDHK4. In primary neurons, Compound A enhanced pyruvate and lactate utilization, but did not change glucose levels. In contrast, in primary astrocytes, Compound A enhanced pyruvate and glucose utilization and enhanced lactate production. In an efficacy study using 5xFAD mice, Compound A ameliorated the cognitive dysfunction in the novel object recognition test and Morris water maze. Moreover, Compound A prevented neuron loss in the hippocampus and cerebral cortex of 5xFAD without affecting amyloid \u03b2 deposits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results suggest ameliorating metabolic deficits by activating PDH by Compound A can limit neurodegeneration and is a promising therapeutic strategy for treating AD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-024-01552-2","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T04:05:29Z","timestamp":1725509129000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["A novel PDHK inhibitor restored cognitive dysfunction and limited neurodegeneration without affecting amyloid pathology in 5xFAD mouse, a model of Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"16","author":[{"given":"Katsuya","family":"Sakimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Nashida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Okuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"issue":"1","key":"1552_CR1","first-page":"CD005593","volume":"2006","author":"J Birks","year":"2006","unstructured":"Birks J. Cholinesterase inhibitors for Alzheimer\u2019s disease. Cochrane Database Syst Rev. 2006;2006(1):CD005593.","journal-title":"Cochrane Database Syst Rev"},{"key":"1552_CR2","doi-asserted-by":"crossref","unstructured":"Birks JS, Grimley J, Evans. Rivastigmine for Alzheimer\u2019s disease. Cochrane Database Syst Rev, 2015(4): p. CD001191.","DOI":"10.1002\/14651858.CD001191.pub3"},{"issue":"7","key":"1552_CR3","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s40266-016-0372-3","volume":"33","author":"CW Wong","year":"2016","unstructured":"Wong CW. Pharmacotherapy for Dementia: a practical Approach to the use of cholinesterase inhibitors and memantine. Drugs Aging. 2016;33(7):451\u201360.","journal-title":"Drugs Aging"},{"issue":"7","key":"1552_CR4","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s40265-023-01858-9","volume":"83","author":"J Cummings","year":"2023","unstructured":"Cummings J. Anti-amyloid monoclonal antibodies are transformative treatments that redefine Alzheimer\u2019s disease therapeutics. Drugs. 2023;83(7):569\u201376.","journal-title":"Drugs"},{"issue":"5","key":"1552_CR5","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/ana.20474","volume":"57","author":"P Bubber","year":"2005","unstructured":"Bubber P, et al. Mitochondrial abnormalities in Alzheimer brain: mechanistic implications. Ann Neurol. 2005;57(5):695\u2013703.","journal-title":"Ann Neurol"},{"issue":"6","key":"1552_CR6","doi-asserted-by":"publisher","first-page":"e67473","DOI":"10.1371\/journal.pone.0067473","volume":"8","author":"L Pliss","year":"2013","unstructured":"Pliss L, et al. Cerebral Developmental Abnormalities in a mouse with systemic pyruvate dehydrogenase Deficiency. PLoS ONE. 2013;8(6):e67473.","journal-title":"PLoS ONE"},{"key":"1552_CR7","doi-asserted-by":"crossref","unstructured":"Jakkamsetti V et al. Brain metabolism modulates neuronal excitability in a mouse model of pyruvate dehydrogenase deficiency. Sci Transl Med, 2019. 11(480).","DOI":"10.1126\/scitranslmed.aan0457"},{"issue":"2","key":"1552_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5603\/FM.a2020.0020","volume":"79","author":"A Ebertowska","year":"2020","unstructured":"Ebertowska A, et al. Pyruvate dehydrogenase deficiency: morphological and metabolic effects, creation of animal model to search for curative treatment. Folia Morphol (Warsz). 2020;79(2):191\u20137.","journal-title":"Folia Morphol (Warsz)"},{"key":"1552_CR9","doi-asserted-by":"crossref","unstructured":"Gao X et al. High expression of PDK4 could play a potentially protective role by attenuating oxidative stress after subarachnoid hemorrhage. J Clin Med, 2022. 11(14).","DOI":"10.3390\/jcm11143974"},{"key":"1552_CR10","doi-asserted-by":"publisher","first-page":"107997","DOI":"10.1016\/j.exer.2020.107997","volume":"193","author":"K Sato","year":"2020","unstructured":"Sato K, et al. A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia\/reperfusion injury. Exp Eye Res. 2020;193:107997.","journal-title":"Exp Eye Res"},{"issue":"1","key":"1552_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ab.2011.01.022","volume":"412","author":"K Saito","year":"2011","unstructured":"Saito K, et al. An enzymatic photometric assay for 2-deoxyglucose uptake in insulin-responsive tissues and 3T3-L1 adipocytes. Anal Biochem. 2011;412(1):9\u201317.","journal-title":"Anal Biochem"},{"issue":"8","key":"1552_CR12","doi-asserted-by":"publisher","first-page":"e0160555","DOI":"10.1371\/journal.pone.0160555","volume":"11","author":"D Saigusa","year":"2016","unstructured":"Saigusa D, et al. Establishment of protocols for global metabolomics by LC-MS for Biomarker Discovery. PLoS ONE. 2016;11(8):e0160555.","journal-title":"PLoS ONE"},{"key":"1552_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1750-1326-8-2","volume":"8","author":"WA Eimer","year":"2013","unstructured":"Eimer WA, Vassar R. Neuron loss in the 5XFAD mouse model of Alzheimer\u2019s disease correlates with intraneuronal Abeta42 accumulation and Caspase-3 activation. Mol Neurodegener. 2013;8:2.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"1552_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cmet.2013.11.020","volume":"19","author":"MS Goyal","year":"2014","unstructured":"Goyal MS, et al. Aerobic glycolysis in the human brain is associated with development and neotenous gene expression. Cell Metab. 2014;19(1):49\u201357.","journal-title":"Cell Metab"},{"issue":"17","key":"1552_CR15","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1016\/j.molcel.2022.08.004","volume":"82","author":"HCD Medeiros","year":"2022","unstructured":"Medeiros HCD, Lunt SY. The Warburg effect: saturation of mitochondrial NADH shuttles triggers aerobic lactate fermentation. Mol Cell. 2022;82(17):3119\u201321.","journal-title":"Mol Cell"},{"issue":"6","key":"1552_CR16","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.neuron.2023.12.015","volume":"112","author":"D Yang","year":"2024","unstructured":"Yang D, et al. Phosphorylation of pyruvate dehydrogenase inversely associates with neuronal activity. Neuron. 2024;112(6):959\u2013e9718.","journal-title":"Neuron"},{"issue":"1","key":"1552_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/cercor\/6.1.50","volume":"6","author":"PJ Magistretti","year":"1996","unstructured":"Magistretti PJ, Pellerin L. Cellular bases of brain energy metabolism and their relevance to functional brain imaging: evidence for a prominent role of astrocytes. Cereb Cortex. 1996;6(1):50\u201361.","journal-title":"Cereb Cortex"},{"issue":"4","key":"1552_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrn.2018.19","volume":"19","author":"PJ Magistretti","year":"2018","unstructured":"Magistretti PJ, Allaman I. Lactate in the brain: from metabolic end-product to signalling molecule. Nat Rev Neurosci. 2018;19(4):235\u201349.","journal-title":"Nat Rev Neurosci"},{"key":"1552_CR19","doi-asserted-by":"publisher","first-page":"6807","DOI":"10.1038\/ncomms7807","volume":"6","author":"I Lundgaard","year":"2015","unstructured":"Lundgaard I, et al. Direct neuronal glucose uptake heralds activity-dependent increases in cerebral metabolism. Nat Commun. 2015;6:6807.","journal-title":"Nat Commun"},{"issue":"8","key":"1552_CR20","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/jnr.24374","volume":"97","author":"CM Diaz-Garcia","year":"2019","unstructured":"Diaz-Garcia CM, Yellen G. Neurons rely on glucose rather than astrocytic lactate during stimulation. J Neurosci Res. 2019;97(8):883\u20139.","journal-title":"J Neurosci Res"},{"issue":"3","key":"1552_CR21","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.mito.2006.04.001","volume":"6","author":"K Berendzen","year":"2006","unstructured":"Berendzen K, et al. Therapeutic potential of dichloroacetate for pyruvate dehydrogenase complex deficiency. Mitochondrion. 2006;6(3):126\u201335.","journal-title":"Mitochondrion"},{"key":"1552_CR22","doi-asserted-by":"publisher","first-page":"1077461","DOI":"10.3389\/fonc.2023.1077461","volume":"13","author":"DO Kamson","year":"2023","unstructured":"Kamson DO, et al. In-vivo magnetic resonance spectroscopy of lactate as a non-invasive biomarker of dichloroacetate activity in cancer and non-cancer central nervous system disorders. Front Oncol. 2023;13:1077461.","journal-title":"Front Oncol"},{"key":"1552_CR23","doi-asserted-by":"crossref","unstructured":"Harris RA et al. Aerobic glycolysis is required for spatial memory Acquisition but Not Memory Retrieval in mice. eNeuro, 2019. 6(1).","DOI":"10.1523\/ENEURO.0389-18.2019"},{"key":"1552_CR24","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3389\/fmed.2020.00529","volume":"7","author":"TN Franke","year":"2020","unstructured":"Franke TN, et al. In vivo imaging with (18)F-FDG- and (18)F-Florbetaben-PET\/MRI detects pathological changes in the brain of the commonly used 5XFAD mouse model of Alzheimer\u2019s Disease. Front Med (Lausanne). 2020;7:529.","journal-title":"Front Med (Lausanne)"},{"key":"1552_CR25","doi-asserted-by":"publisher","first-page":"850538","DOI":"10.3389\/fcvm.2022.850538","volume":"9","author":"J Murphy","year":"2022","unstructured":"Murphy J, et al. The Cardiac Dysfunction caused by metabolic alterations in Alzheimer\u2019s Disease. Front Cardiovasc Med. 2022;9:850538.","journal-title":"Front Cardiovasc Med"},{"key":"1552_CR26","doi-asserted-by":"crossref","unstructured":"Choi M et al. Effect Sizes of Cognitive and Locomotive Behavior Tests in the 5XFAD-J Mouse Model of Alzheimer\u2019s Disease. Int J Mol Sci, 2023. 24(20).","DOI":"10.3390\/ijms242015064"},{"issue":"6","key":"1552_CR27","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1037\/0735-7044.110.6.1321","volume":"110","author":"CD Conrad","year":"1996","unstructured":"Conrad CD, et al. Chronic stress impairs rat spatial memory on the Y maze, and this effect is blocked by tianeptine pretreatment. Behav Neurosci. 1996;110(6):1321\u201334.","journal-title":"Behav Neurosci"},{"key":"1552_CR28","doi-asserted-by":"crossref","unstructured":"Traxler L et al. Metabolism navigates neural cell fate in development, aging and neurodegeneration. Dis Model Mech, 2021. 14(8).","DOI":"10.1242\/dmm.048993"},{"key":"1552_CR29","doi-asserted-by":"publisher","first-page":"937133","DOI":"10.3389\/fnmol.2022.937133","volume":"15","author":"P Goel","year":"2022","unstructured":"Goel P, et al. Neuronal cell death mechanisms in Alzheimer\u2019s disease: an insight. Front Mol Neurosci. 2022;15:937133.","journal-title":"Front Mol Neurosci"},{"issue":"9","key":"1552_CR30","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/nn.4608","volume":"20","author":"A Caccamo","year":"2017","unstructured":"Caccamo A, et al. Necroptosis activation in Alzheimer\u2019s disease. Nat Neurosci. 2017;20(9):1236\u201346.","journal-title":"Nat Neurosci"},{"issue":"6663","key":"1552_CR31","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1126\/science.abp9556","volume":"381","author":"S Balusu","year":"2023","unstructured":"Balusu S, et al. MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer\u2019s disease. Science. 2023;381(6663):1176\u201382.","journal-title":"Science"},{"issue":"1","key":"1552_CR32","doi-asserted-by":"publisher","first-page":"e0255715","DOI":"10.1371\/journal.pone.0255715","volume":"17","author":"ET Parkin","year":"2022","unstructured":"Parkin ET, et al. The orphan drug dichloroacetate reduces amyloid beta-peptide production whilst promoting non-amyloidogenic proteolysis of the amyloid precursor protein. PLoS ONE. 2022;17(1):e0255715.","journal-title":"PLoS ONE"},{"issue":"3","key":"1552_CR33","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jalz.2017.09.011","volume":"14","author":"Y An","year":"2018","unstructured":"An Y, et al. Evidence for brain glucose dysregulation in Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(3):318\u201329.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"1552_CR34","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1046\/j.1471-4159.2001.00033.x","volume":"76","author":"JL Mazzola","year":"2001","unstructured":"Mazzola JL, Sirover MA. Reduction of glyceraldehyde-3-phosphate dehydrogenase activity in Alzheimer\u2019s disease and in Huntington\u2019s disease fibroblasts. J Neurochem. 2001;76(2):442\u20139.","journal-title":"J Neurochem"},{"issue":"34","key":"1552_CR35","doi-asserted-by":"publisher","first-page":"14670","DOI":"10.1073\/pnas.0903563106","volume":"106","author":"J Yao","year":"2009","unstructured":"Yao J, et al. Mitochondrial bioenergetic deficit precedes Alzheimer\u2019s pathology in female mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2009;106(34):14670\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"49","key":"1552_CR36","doi-asserted-by":"publisher","first-page":"18727","DOI":"10.1073\/pnas.0606298103","volume":"103","author":"X Sun","year":"2006","unstructured":"Sun X, et al. Hypoxia facilitates Alzheimer\u2019s disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci U S A. 2006;103(49):18727\u201332.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1552_CR37","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s10571-016-0440-6","volume":"37","author":"O Iyalomhe","year":"2017","unstructured":"Iyalomhe O, et al. The role of Hypoxia-Inducible factor 1 in mild cognitive impairment. Cell Mol Neurobiol. 2017;37(6):969\u201377.","journal-title":"Cell Mol Neurobiol"},{"issue":"10","key":"1552_CR38","first-page":"778","volume":"7","author":"H Wang","year":"2012","unstructured":"Wang H, et al. Increased hypoxia-inducible factor 1alpha expression in rat brain tissues in response to aging. Neural Regen Res. 2012;7(10):778\u201382.","journal-title":"Neural Regen Res"},{"key":"1552_CR39","doi-asserted-by":"publisher","first-page":"648115","DOI":"10.3389\/fnagi.2021.648115","volume":"13","author":"Y Guo","year":"2021","unstructured":"Guo Y, et al. The Association of Suppressed Hypoxia-Inducible Factor-1 transactivation of Angiogenesis with defective recovery from cerebral ischemic Injury in aged rats. Front Aging Neurosci. 2021;13:648115.","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"1552_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","volume":"3","author":"JW Kim","year":"2006","unstructured":"Kim JW, et al. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 2006;3(3):177\u201385.","journal-title":"Cell Metab"},{"issue":"42","key":"1552_CR41","doi-asserted-by":"publisher","first-page":"28106","DOI":"10.1074\/jbc.M803508200","volume":"283","author":"CW Lu","year":"2008","unstructured":"Lu CW, et al. Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance. J Biol Chem. 2008;283(42):28106\u201314.","journal-title":"J Biol Chem"},{"issue":"9","key":"1552_CR42","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00702-019-01988-z","volume":"126","author":"CM Escher","year":"2019","unstructured":"Escher CM, Sannemann L, Jessen F. Stress and Alzheimer\u2019s disease. J Neural Transm (Vienna). 2019;126(9):1155\u201361.","journal-title":"J Neural Transm (Vienna)"},{"key":"1552_CR43","doi-asserted-by":"crossref","unstructured":"Saiz-Vazquez O et al. Depression as a Risk Factor for Alzheimer\u2019s Disease: A Systematic Review of Longitudinal Meta-Analyses. J Clin Med, 2021. 10(9).","DOI":"10.3390\/jcm10091809"},{"key":"1552_CR44","doi-asserted-by":"crossref","unstructured":"Wang C et al. Targeting PDK2 rescues stress-induced impaired brain energy metabolism. Mol Psychiatry, 2023.","DOI":"10.1038\/s41380-023-02098-9"},{"issue":"1","key":"1552_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s40336-014-0094-7","volume":"3","author":"AG Vlassenko","year":"2015","unstructured":"Vlassenko AG, Raichle ME. Brain aerobic glycolysis functions and Alzheimer\u2019s disease. Clin Transl Imaging. 2015;3(1):27\u201337.","journal-title":"Clin Transl Imaging"},{"issue":"11","key":"1552_CR46","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1038\/jcbfm.2009.97","volume":"29","author":"C Berthet","year":"2009","unstructured":"Berthet C, et al. Neuroprotective role of lactate after cerebral ischemia. J Cereb Blood Flow Metab. 2009;29(11):1780\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1552_CR47","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3389\/fnins.2020.00460","volume":"14","author":"S Mason","year":"2020","unstructured":"Mason S. A Novel, multi-faceted perception of Lactate in Neurology. Front Neurosci. 2020;14:460.","journal-title":"Front Neurosci"},{"issue":"9","key":"1552_CR48","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41573-020-0072-x","volume":"19","author":"SC Cunnane","year":"2020","unstructured":"Cunnane SC, et al. Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing. Nat Rev Drug Discov. 2020;19(9):609\u201333.","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"1552_CR49","first-page":"50","volume":"9","author":"LP Saenz Martinez","year":"1988","unstructured":"Saenz Martinez LP, Prea BJ, Licona, Gonzalez Olguin A. Prevalence of dental caries by high, average and low risk. Pract Odontol. 1988;9(11):50\u20131.","journal-title":"Pract Odontol"},{"issue":"11","key":"1552_CR50","doi-asserted-by":"publisher","first-page":"6170","DOI":"10.1073\/pnas.1913042117","volume":"117","author":"LR Mujica-Parodi","year":"2020","unstructured":"Mujica-Parodi LR, et al. Diet modulates brain network stability, a biomarker for brain aging, in young adults. Proc Natl Acad Sci U S A. 2020;117(11):6170\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1552_CR51","doi-asserted-by":"crossref","unstructured":"Weistuch C et al. Metabolism modulates network synchrony in the aging brain. Proc Natl Acad Sci U S A, 2021. 118(40).","DOI":"10.1073\/pnas.2025727118"},{"key":"1552_CR52","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neurobiolaging.2022.04.005","volume":"115","author":"M Roy","year":"2022","unstructured":"Roy M, et al. A ketogenic intervention improves dorsal attention network functional and structural connectivity in mild cognitive impairment. Neurobiol Aging. 2022;115:77\u201387.","journal-title":"Neurobiol Aging"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01552-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-024-01552-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01552-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T05:06:50Z","timestamp":1725512810000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-024-01552-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1552"],"URL":"https:\/\/doi.org\/10.1186\/s13195-024-01552-2","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,5]]},"assertion":[{"value":"28 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"197"}}